Related Experiment Video

Updated: Jun 14, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors

Annika Schaefer1, Carsten Stephan, Jonas Busch

  • 1Department of Biology, Free University Berlin, Germany.

Nature Reviews. Urology
|April 7, 2010
PubMed

Insights

MicroRNAs (miRNAs) are small RNAs crucial in cancer. This review explores their role in urologic tumors, highlighting their potential as diagnostic biomarkers and therapeutic targets for improved patient outcomes.

Area of Science:

  • Urologic Oncology
  • Molecular Biology
  • Biomarker Research

Background:

  • MicroRNAs (miRNAs) are small, non-coding RNAs regulating gene expression.
  • Aberrant miRNA expression is observed in various cancers, including urologic tumors.
  • miRNAs play roles in key carcinogenic pathways.

Purpose of the Study:

  • To review current research on miRNA function in urologic tumors.
  • To highlight the potential of miRNAs as diagnostic and prognostic biomarkers.
  • To discuss miRNAs as therapeutic targets for urologic malignancies.

Main Methods:

  • Literature review of published articles on miRNAs in urologic oncology.
  • Analysis of miRNA expression patterns in tumor versus normal tissues.
  • Evaluation of miRNA involvement in carcinogenesis and therapeutic strategies.

Main Results:

  • Increasing number of publications indicate growing importance of miRNAs in urologic oncology.
  • Differential expression of miRNAs in urologic tumors suggests biomarker potential.
  • miRNAs are implicated in regulating critical steps of carcinogenesis.

Conclusions:

  • miRNAs hold significant promise as biomarkers for diagnosis, prognosis, and monitoring in urologic cancers.
  • miRNA-targeted therapies offer novel treatment avenues, especially for resistant tumor subtypes.
  • Further research is essential to translate miRNA findings into clinical practice for urologic oncology.

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...